Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For

Eur J Nucl Med Mol Imaging. 2002 May;29(5):711-4. doi: 10.1007/s00259-002-0814-5. Epub 2002 Mar 23.

Author

Affiliation

¹ Department of Nuclear Medicine, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Marchioninistrasse 15, 81377 Munich, Germany. tatsch@nuk.med.uni-muenchen.de

PMID: 11976813
DOI: 10.1007/s00259-002-0814-5

No abstract available

Publication types

Comparative Study

MeSH terms

Brain / diagnostic imaging
Brain / metabolism
Disease Progression
Dopamine / metabolism*
Dopamine Plasma Membrane Transport Proteins
Fluorine Radioisotopes / pharmacokinetics
Humans
Membrane Glycoproteins*
Membrane Transport Proteins / metabolism
Nerve Tissue Proteins*
Parkinson Disease / diagnostic imaging*
Parkinson Disease / metabolism*
Tomography, Emission-Computed / instrumentation
Tomography, Emission-Computed / methods
Tomography, Emission-Computed, Single-Photon / instrumentation
Tomography, Emission-Computed, Single-Photon / methods*

Substances

Dopamine Plasma Membrane Transport Proteins
Fluorine Radioisotopes
Membrane Glycoproteins
Membrane Transport Proteins
Nerve Tissue Proteins
Dopamine